Fujian Aonong Biological Technology Group Incorporation Limited (603363.SS)
CNY 3.69
(-0.27%)
CNY 3.69
(-0.27%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 8.22 Billion CNY | -0.36% |
| 2022 | 8.25 Billion CNY | -4.74% |
| 2021 | 8.66 Billion CNY | 120.65% |
| 2020 | 3.92 Billion CNY | 206.88% |
| 2019 | 1.28 Billion CNY | 19.66% |
| 2018 | 1.06 Billion CNY | 104.79% |
| 2017 | 522.41 Million CNY | 147.81% |
| 2016 | 210.8 Million CNY | 401.85% |
| 2015 | 42 Million CNY | -56.03% |
| 2014 | 95.52 Million CNY | 232.34% |
| 2013 | -72.17 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 7.44 Billion CNY | -7.25% |
| 2024 Q1 | 8.02 Billion CNY | -2.43% |
| 2024 Q3 | 6.44 Billion CNY | -45.39% |
| 2023 Q4 | 8.22 Billion CNY | -1.37% |
| 2023 Q2 | 8.51 Billion CNY | 1.27% |
| 2023 Q1 | 8.4 Billion CNY | 1.82% |
| 2023 FY | 8.22 Billion CNY | -0.36% |
| 2023 Q3 | 8.34 Billion CNY | -2.02% |
| 2022 Q1 | 9.27 Billion CNY | 6.97% |
| 2022 FY | 8.25 Billion CNY | -4.74% |
| 2022 Q4 | 8.25 Billion CNY | 0.08% |
| 2022 Q2 | 8.91 Billion CNY | -3.89% |
| 2022 Q3 | 8.25 Billion CNY | -7.41% |
| 2021 Q2 | 7.61 Billion CNY | 16.87% |
| 2021 Q3 | 8.2 Billion CNY | 7.71% |
| 2021 Q4 | 8.66 Billion CNY | 5.62% |
| 2021 FY | 8.66 Billion CNY | 120.65% |
| 2021 Q1 | 6.51 Billion CNY | 65.97% |
| 2020 Q2 | 1.43 Billion CNY | -9.44% |
| 2020 Q4 | 3.92 Billion CNY | 26.41% |
| 2020 Q3 | 3.1 Billion CNY | 115.86% |
| 2020 FY | 3.92 Billion CNY | 206.88% |
| 2020 Q1 | 1.58 Billion CNY | 24.18% |
| 2019 Q4 | 1.28 Billion CNY | 3.42% |
| 2019 FY | 1.28 Billion CNY | 19.66% |
| 2019 Q2 | 1.1 Billion CNY | 3.53% |
| 2019 Q3 | 1.23 Billion CNY | 11.93% |
| 2019 Q1 | 1.06 Billion CNY | -0.16% |
| 2018 Q2 | 824.17 Million CNY | 2.37% |
| 2018 FY | 1.06 Billion CNY | 104.79% |
| 2018 Q4 | 1.06 Billion CNY | 9.45% |
| 2018 Q3 | 977.46 Million CNY | 18.6% |
| 2018 Q1 | 805.09 Million CNY | 54.11% |
| 2017 FY | 522.41 Million CNY | 147.81% |
| 2017 Q1 | 174.26 Million CNY | -17.33% |
| 2017 Q2 | 220.39 Million CNY | 26.47% |
| 2017 Q3 | 171.03 Million CNY | -22.4% |
| 2017 Q4 | 522.41 Million CNY | 205.44% |
| 2016 Q4 | 210.8 Million CNY | 0.0% |
| 2016 FY | 210.8 Million CNY | 401.85% |
| 2015 FY | 42 Million CNY | -56.03% |
| 2014 FY | 95.52 Million CNY | 232.34% |
| 2013 FY | -72.17 Million CNY | 0.0% |